
Pelthos Therapeutics Inc.
PTHSHealthcare|Biotechnology|US
$9.36
+0.06 (+0.65%)
DCF Value
$113.99
Cash / Share
$6.94
Next Earnings Report
Nov 12, 2026
EPS est. -$3.08 · Revenue est. $16.9M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Feb 13, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
Nov 4, 2026 · GlobeNewsWire
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Oct 30, 2026 · GlobeNewsWire
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
Oct 27, 2026 · GlobeNewsWire
Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
Oct 6, 2026 · GlobeNewsWire
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
Aug 13, 2026 · GlobeNewsWire
SEC Filings (71)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 30, 2026 | 425 | DocumentIndex | |
| Oct 30, 2026 | 425 | DocumentIndex | |
| Oct 30, 2026 | 8-K | Material event | DocumentIndex |
| May 28, 2026 | 8-K | Material event | DocumentIndex |
| May 21, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 14, 2026 | 8-K | Material event | DocumentIndex |
| Apr 10, 2026 | 8-K | Material event | DocumentIndex |
| Mar 19, 2026 | 8-K | Material event | DocumentIndex |
| Mar 19, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Feb 9, 2026 | EFFECT | DocumentIndex | |
| Feb 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 2, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 13, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 2, 2026 | 8-K | Material event | DocumentIndex |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |
| Dec 17, 2025 | 8-K | Material event | DocumentIndex |
| Dec 1, 2025 | ARS | Annual report to holders | DocumentIndex |
| Nov 25, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Nov 19, 2025 | D | DocumentIndex | |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 10, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 7, 2025 | 8-K | Material event | DocumentIndex |
| Oct 14, 2025 | 8-K | Material event | DocumentIndex |
| Sep 29, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 24, 2025 | EFFECT | DocumentIndex | |
| Sep 19, 2025 | S-3/A | Shelf registration | DocumentIndex |
| Sep 16, 2025 | 8-K/A | Material event | DocumentIndex |
| Sep 3, 2025 | 8-K | Material event | DocumentIndex |